Vor Biopharma Inc.
VOR
$0.2236
-$0.0002-0.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.36% | 0.81% | 2.64% | -11.29% | -22.95% |
| Total Depreciation and Amortization | -5.23% | 1.03% | 9.99% | 87.34% | 22.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.85% | 2.17% | -20.22% | -33.70% | -16.70% |
| Change in Net Operating Assets | 153.24% | -99.23% | -334.64% | -768.36% | 61.15% |
| Cash from Operations | 5.85% | 0.63% | -5.30% | -21.75% | -23.10% |
| Capital Expenditure | 68.23% | 78.58% | 79.05% | 37.14% | 83.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.63% | 34.70% | 406.50% | 335.45% | 248.08% |
| Cash from Investing | -51.46% | 36.40% | 394.98% | 330.28% | 234.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,658.22% | 1,057.58% | -99.61% | -99.39% | -98.77% |
| Repurchase of Common Stock | 78.74% | 71.95% | 72.10% | 49.74% | -142.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -224.27% | 100.00% | 100.00% | 100.00% |
| Cash from Financing | 10,131.07% | 1,717.29% | -99.89% | -99.78% | -99.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.59% | 292.02% | 149.19% | 242.69% | 105.27% |